SYNBIAS PHARMA
Live / Registered — Registered and renewed (as of 23 Sept 2024)
What this means for you
Registered since 08 Jul 2014. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 08 Jul 2024).
Record
- Serial number
- 85804015
- Registration number
- 4562242
- Mark type
- Stylized text
- Filed
- 17 Dec 2012
- Published for opposition
- 22 Apr 2014
- Registered
- 08 Jul 2014
- Next maintenance due
- 08 Jul 2024
- Attorney of record
- Thomas W. Brooke
Goods and services
- Class 001 — Chemicals: Chemicals for use in industry and science; preservatives for pharmaceutical preparations; chemical preparations for pharmaceutical purposes, namely, active chemical ingredients for the manufacture of finished pharmaceuticals for treating various kinds of cancer diseases, diseases of the immunological system, namely, auto-immune diseases, and for prevention of organ rejection after transplantation
- Class 005 — Pharmaceuticals: Human pharmaceutical preparations for treating various kinds of cancer diseases, diseases of the immunological system, namely, auto-immune diseases, and for prevention of organ rejection after transplantation
- Class 042 — Scientific and technological services: Scientific and technological services, namely, research, design, evaluations and engineering appraisals in the fields of chemical intermediates, active pharmaceutical ingredients and pharmaceutical finished products, provided by engineers; industrial analysis and research services in the field of chemical intermediates, active pharmaceutical ingredients and pharmaceutical finished products; engineering; research in the field of chemical research; chemical analysis; chemistry services, namely, chemistry consultation, research in the field of chemistry, optimization of chemical processes, analysis for polymorphism determination; research and development of new pharmaceutical preparations for others; biological research; drug and pharmaceutical research services; bacteriological research
Owner
- Synbias Pharma AG, 8200 Schaffhausen, CH
- Synbias Pharma AG, 8200 Schaffhausen, CH
- Synbias Pharma AG, 8200 Schaffhausen, CH
Prosecution history
- 23 Sept 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 23 Sept 2024 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 23 Sept 2024 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 23 Sept 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 05 Jul 2024 — TEAS SECTION 8 & 9 RECEIVED
- 08 Jul 2023 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 16 Sept 2020 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 16 Sept 2020 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 12 Sept 2020 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 01 Jul 2020 — TEAS SECTION 8 & 15 RECEIVED
- 08 Jul 2019 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 08 Jul 2014 — REGISTERED-PRINCIPAL REGISTER
- 22 Apr 2014 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 22 Apr 2014 — PUBLISHED FOR OPPOSITION
- 02 Apr 2014 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED